AU2645299A - 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity - Google Patents

6-(3-carboxymethylphenyl)-aminouracyl having a biological activity

Info

Publication number
AU2645299A
AU2645299A AU26452/99A AU2645299A AU2645299A AU 2645299 A AU2645299 A AU 2645299A AU 26452/99 A AU26452/99 A AU 26452/99A AU 2645299 A AU2645299 A AU 2645299A AU 2645299 A AU2645299 A AU 2645299A
Authority
AU
Australia
Prior art keywords
aminouracyl
carboxymethylphenyl
biological activity
biological
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26452/99A
Inventor
Elena Alexandrovna Izaxon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2645299A publication Critical patent/AU2645299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26452/99A 1998-11-18 1998-11-18 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity Abandoned AU2645299A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU1998/000387 WO2000029389A1 (en) 1998-11-18 1998-11-18 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity

Publications (1)

Publication Number Publication Date
AU2645299A true AU2645299A (en) 2000-06-05

Family

ID=20130294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26452/99A Abandoned AU2645299A (en) 1998-11-18 1998-11-18 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity

Country Status (3)

Country Link
AU (1) AU2645299A (en)
RU (1) RU2207337C2 (en)
WO (1) WO2000029389A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2260590C1 (en) * 2004-04-20 2005-09-20 Тец Виктор Вениаминович 2,4-dioxo-5-(2-hydroxy-3,5-dichlorobenzylidene)imino-1,3-pyrimidine salts
RU2427373C1 (en) * 2010-11-08 2011-08-27 Виктор Вениаминович Тец Method for endogenous interferon induction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0054132B1 (en) * 1980-12-12 1984-10-10 Dr. Karl Thomae GmbH Pyrimidones, their preparation and medicines containing them
EP0517181B1 (en) * 1991-06-07 1995-09-20 Sumitomo Chemical Company Limited Amino uracil derivatives, and their production and use
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof

Also Published As

Publication number Publication date
WO2000029389A1 (en) 2000-05-25
RU2207337C2 (en) 2003-06-27
RU2001114504A (en) 2004-03-20

Similar Documents

Publication Publication Date Title
AU9599498A (en) Biosensor
AU6688398A (en) Intravascular aspiration system
AU1092300A (en) Inventory control
AU8826198A (en) Automated biological reaction system
AU2576699A (en) Erythropoietin with altered biological activity
AU8428098A (en) Self-contained activity module
AU6209098A (en) Herbicidal agent
AU8696398A (en) Automated abrader
AU5293698A (en) Mat
AU2016100A (en) New assay
AU1155499A (en) Pesticidal combination
AU6826898A (en) Pesticidal combination
AU5944898A (en) Catheter
AU2645299A (en) 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity
AU8227898A (en) Biological data
AU6620498A (en) Herbicidal agent
AU6292598A (en) Herbicidal 3-arylamino-6-trifluoromethyl uracyls
AUPO733397A0 (en) Pesticidal compounds
AU6488299A (en) Bio neutralizer-transformer
AUPO717197A0 (en) Improved biosensor
AUPP148098A0 (en) Assay
AU2450299A (en) Rambus stakpak
AU6725698A (en) Algicidal agents
AUPP498598A0 (en) Activity wallet
AU751001C (en) Automated biogenerator

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase